Novocure Inc.

Novocure Inc.

Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for treatment of adult patients with glioblastoma, non-small cell lung cancer, malignant pleural mesothelioma and pleural mesothelioma. Novocure has several ongoing or completed clinical trials exploring the use of Tumor Treating Fields therapy in the treatment of glioblastoma, non-small cell lung and pancreatic cancer.

Central Nervous System Tumors, Gastrointestinal (Noncolorectal) Cancer, Lung Cancer, Medical Devices/Equipment/Supplies

Yes